Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2022 Mar 24;139(12):1780-1781.
doi: 10.1182/blood.2021015022.

The many facets of liquid biopsies in lymphoma

David M Kurtz  1
Affiliations
Editorial

The many facets of liquid biopsies in lymphoma

David M Kurtz. Blood. .
No abstract available

PubMed Disclaimer

Conflict of interest statement

Conflict-of-interest disclosure: D.M.K. has served as a consultant for Roche and Genentech, has ownership equity in Foresight Diagnostics, and has patents pending related to methods for analysis of cell free nucleic acids and methods for treatment selection based on statistical frameworks of clinical outcome.

Figures

None
Multiple dimensions of cell-free DNA in lymphomas. The study from Meriranta et al examines multiple aspects of cell-free DNA in large B-cell lymphomas, including pretreatment disease quantification (A), molecular response assessment (B), mutational genotyping (C), and DNA fragmentation patterns (D). Each feature of cell-free DNA molecules has potential for translation into the clinic as a prognostic biomarker.
See this image and copyright information in PMC

Comment on

References

    1. Meriranta L, Alkodsi A, Pasanen A, et al. . Molecular features encoded in the ctDNA reveal heterogeneity and predict outcome in high-risk aggressive B-cell lymphoma. Blood. 2022;139(12): 1863-1877. - PubMed
    1. Kurtz DM, Green MR, Bratman SV, et al. . Noninvasive monitoring of diffuse large B-cell lymphoma by immunoglobulin high-throughput sequencing. Blood. 2015; 125(24):3679-3687. - PMC - PubMed
    1. Roschewski M, Dunleavy K, Pittaluga S, et al. . Circulating tumour DNA and CT monitoring in patients with untreated diffuse large B-cell lymphoma: a correlative biomarker study. Lancet Oncol. 2015;16(5):541-549. - PMC - PubMed
    1. Kurtz DM, Scherer F, Jin MC, et al. . Circulating tumor DNA measurements as early outcome predictors in diffuse large B-cell lymphoma. J Clin Oncol. 2018;36(28):2845-2853. - PMC - PubMed
    1. Rossi D, Diop F, Spaccarotella E, et al. . Diffuse large B-cell lymphoma genotyping on the liquid biopsy. Blood. 2017;129(14):1947-1957. - PubMed